Search

Author/Creator Famulla, Susanne

1. A co‐formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes. Issue 5 (31st January 2023)

Authors:
Andersen, Grit; Eloy, Rosy; Famulla, Susanne; Heise, Tim; Meiffren, Grégory; Seroussi, Cyril; Gaudier, Martin; Mégret, Claire; Chan, You‐Ping; Soula, Olivier; Riddle, Matthew
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 25:Issue 5(2023)
Page Start:
1241
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. ADO09, a co‐formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes. Issue 4 (18th January 2021)

Authors:
Andersen, Grit; Meiffren, Grégory; Famulla, Susanne; Heise, Tim; Ranson, Aymeric; Seroussi, Cyril; Eloy, Rosy; Gaudier, Martin; Charvet, Richard; Chan, You‐Ping; Soula, Olivier; DeVries, J. Hans
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 23:Issue 4(2021)
Page Start:
961
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Evaluation of Insulin Lispro Pharmacokinetics and Pharmacodynamics Over 10 Days of Continuous Insulin Infusion in People With Type 1 Diabetes. (March 2023)

Authors:
Garhyan, Parag; Pratt, Edward; Klein, Oliver; Famulla, Susanne; Zijlstra, Eric; Lalonde, Amy; Swinney, Monica; Kazda, Christof; Dassau, Eyal
Journal:
Journal of diabetes science and technology
Issue:
Volume 17:Number 2(2023)
Page Start:
274
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗